TITLE

2009 - Review: Differences in efficacy and acceptability exist for 12 new-generation antidepressants for major depression

AUTHOR(S)
Usherwood, Tim
PUB. DATE
July 2009
SOURCE
ACP Journal Club;7/21/2009, Vol. 151 Issue 1, p8
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on a study of the relative efficacy of 12 new-generation antidepressants for relieving major depression. The study was conducted through randomized controlled trials (RCTs). The study concluded that new-generation antidepressants differ in efficacy and acceptability in patients with major depression.
ACCESSION #
43797544

 

Related Articles

  • Cost Effectiveness of Fluvoxamine in the Treatment of Recurrent Depression in France. Nuijten, M.; Hadjadjeba, L.; Evans, C.; van den Berg, J. // PharmacoEconomics;1998, Vol. 14, p433 

    Objective: The objective of this study was to examine the cost effectiveness of fluvoxamine compared with tricyclic antidepressants (TCAs) in the treatment of patients with depressive episodes. Design and Setting: A Markov process model was constructed to model the effectiveness, as measured by...

  • Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials. Barbui, Corrado; Hotopf, Matthew // British Journal of Psychiatry;Feb2001, Vol. 178, p129 

    Background Tricyclic antidepressants have similar efficacy and slightly lower tolerability than selective serotonin reuptake inhibitors (SSRIs). However, there are no systematic reviews assessing amitriptyline, the reference tricyclic drug, v. other tricyclics and SSRIs directly. Aims To review...

  • Depressed? Just pop the Prozac. Daniel, Caroline // New Statesman;09/19/97, Vol. 126 Issue 4352, p18 

    Examines the use of drugs to combat mental depression. Reasons for the public's wariness on the use of antidepressants; Life events as cause of depression; Developments in antidepressants; Debate over the chemical and social causes of depression.

  • Ask the Pharmacist. Harkness, Richard // Prevention;Aug2010, Vol. 62 Issue 8, p16 

    An answer to a question on how to stop taking antidepressants is presented.

  • Effects of antidepressants more widespread than thought.  // Mental Health Today;Mar/Apr2014, p6 

    No abstract available.

  • Are antidepressants overprescribed? YES. Spence, Des // BMJ: British Medical Journal;5/11/2013, Vol. 346 Issue 7907, p16 

    The article discusses whether the antidepressants are overprescribed or not. It is mentioned that antidepressant prescriptions has raised by 9.6 percent in the Great Britain in 2011 which are 46 million prescriptions. It mentions that according to the Diagnostic and Statistical Manual of Mental...

  • Are antidepressants overprescribed? NO. Reid, Ian C. // BMJ: British Medical Journal;5/11/2013, Vol. 346 Issue 7907, p16 

    The author refutes the notion that antidepressants are over-prescribed, arguing that depression is still under-recognized and under-treated. He argues that the rise in antidepressant use is driven by small, appropriate increases in the duration of antidepressant prescription and not by a growing...

  • Killing the QOF won't decrease prescribing for depression. Kendrick, Tony // BMJ: British Medical Journal;5/11/2013, Vol. 346 Issue 7907, p24 

    A letter to the editor is presented in response to the article "The Quality and Outcomes Framework--where next?" by S. Gillam and N. Steel in the February 7, 2013 issue.

  • Mirtazapine: A newer antidepressant. HARTMANN, PETER M. // American Family Physician;1/1/1999, Vol. 59 Issue 1, p159 

    Focuses on mirtazapine, an antidepressant drug released in the United States. Pharmacological background of the drug; Efficacy of the drug; Side effects of the drug.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics